Fixed drug eruption to tartrazine

Australasian Journal of Dermatology

Volumn 38, Issue 4, 1997, Pages 212-214

  Orchard, David C ^a,b   Varigos, George A ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Azo compounds; Fixed cutaneous eruption

Indexed keywords

FOOD DYE; TARTRAZINE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG ERUPTION; FEMALE; FOOD ALLERGY; HUMAN; PROVOCATION TEST; SCHOOL CHILD;

EID: 0030810171     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1997.tb01701.x     Document Type: Article

References (13)

1. Brocq L. Iruption érytheniato-pigmentc fixe duc àl'antipyrinc. Ann. Dcrmatol. Syphiligr. 1894: 5: 308-13 (in French).
2. Lisi P, Stingeni L. Fixed drug eruption: Bullous form. Clin. Dennatol. 1993; 11:461-6.
3. Commens C. Fixed drug eruption, stustralas. J. Dennatol. 1983; 24: 1-8.
4. Kamvar AJ, Bclhaj MS, Bliarija SG et al. Drugs causing fixed eruptions. J. Dennatol. 1984; 11: 383-5.
5. Dipalma JR. Tartrazine sensitivity. Am. Fain. Physician 1990; 42: 1347-50.
6. General requirements for labels for drug products. Theraputic Goods Order No. 48, Second Schedule. Tlierapeulic Goods Act 19S9.
7. Michaelsson G, Pettersson L, Juhlin L. Purpura caused by food and drug allergies. Arch. Dermatol. 1974; 109: 49-52.
8. Roeleveld CG, Ketel WG. Positive patch test to the azo-dye tartrazine. Contact Dermatitis 1976; 2: 180.
9. Rowe KS, Ro\ve K J. Synthetic food colouring and behaviour: A dose response effect in a double-blind, placebo-controlled, repeatedmeasures study. J. Pcdiatr. 1994; 125: 691-8.
10. Hatzis J, Konstantinos N, Hatzidakis E, Bassioukas K, Perissios A. Fixed drug eruption in a mother and her son. Cutis 1992; 50:50-2.
11. Kelso JM. Fixed food eruption. J. Am. Acad, Dermatol. 1996; 55: 638-9.
12. Weiner M, Bernstein IL. Adverse Reactions to Drug Formulation Agents: A Handbook of Excipients, New York: Dekker, 1989; 257-72.
13. Hedman SE, Andersson RG. Release of biological mediators by tartrazine from human leukocytes and polyps. Acta Pharmacol. Toxicol. 1983; 52: 153-4.